SM
ABVC icon

Sabby Management’s ABVC BioPharma ABVC Stock Holding History

Sabby Management’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,156
Closed -$165K – 188
2021
Q3 		$165K Buy
+7,156
New +$203K 0.02% 149

Other funds holding ABVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management's ABVC Position: Q4 2021 in Review

Sabby Management sold out of ABVC BioPharma (ABVC) in Q4 2021, closing a stake of 7,156 shares — an estimated $165K sold.

Sabby Management first reported a position in ABVC in Q3 2021 and held it in 1 quarter. The position peaked at $165K in Q3 2021. 5 funds tracked by Wall St. Rank hold ABVC as of Q4 2021.

  • Sabby Management reported no remaining ABVC BioPharma position as of Q4 2021 after selling out during the quarter.
  • Sabby Management sold 7,156 ABVC BioPharma shares in Q4 2021, an estimated $165K.
  • Sabby Management first reported a position in ABVC BioPharma in Q3 2021 and held it in 1 quarter.
  • Sabby Management's ABVC BioPharma position peaked at $165K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held ABVC BioPharma as of Q4 2021.

Based on Sabby Management's 13F filing for Q4 2021, filed 14 Feb 2022.